miR-145 promotes osteosarcoma growth by reducing expression of the transcription factor friend leukemia virus integration 1.
Osteosarcoma (OS) is the most common malignant bone tumor in children and young adults. miR-145 is a microRNA highly expressed in vascularized tissues and has been widely studied in cancers. In this study, we explored the expression and function of miR-145 in OS. We found that miR-145 was consistently under-expressed in OS tissues and cell lines as compared to normal bone tissues and osteoblast cells. Ectopic expression of miR-145 in OS cells inhibited their proliferation and migration and induced apoptosis. miR-145 targets a putative microRNA regulatory element (MRE) in the 3'-UTR of friend leukemia virus integration 1 gene (FLI-1), and its abundance was inversely related to FLI-1 expression in OS tissues and cell lines. miR-145 decreased expression FLI-1 protein and mRNA, but mutation of the miR-145 MRE sequence in the FLI-1 3'-UTR abolished the activity of miR-145 in a reporter assay. Restored expression of FLI-1 diminished miR-145-mediated suppression of tumor progression. These results suggest that miR-145 acts as a tumor suppressor by directly reducing expression of FLI-1, and that the miR-145/FLI-1 pathway is important for tumor progression in OS.
Department of Orthopedics, Xiang Ya Hospital Central South University, Changsha, Hunan, People's Republic of China.
Panfeng
P
Wu
Department of Orthopedics, Xiang Ya Hospital Central South University, Changsha, Hunan, People's Republic of China.
Jieyu
J
Liang
Department of Orthopedics, Xiang Ya Hospital Central South University, Changsha, Hunan, People's Republic of China.
Fang
F
Yu
Department of Orthopedics, Xiang Ya Hospital Central South University, Changsha, Hunan, People's Republic of China.
Zhengbing
Z
Zhou
Department of Orthopedics, Xiang Ya Hospital Central South University, Changsha, Hunan, People's Republic of China.
Juyu
J
Tang
Department of Orthopedics, Xiang Ya Hospital Central South University, Changsha, Hunan, People's Republic of China.
Kanghua
K
Li
D020413:3' Untranslated Regions; D000818:Animals; D017209:Apoptosis; D001859:Bone Neoplasms / Q000235:genetics* / Q000378:metabolism; D045744:Cell Line, Tumor; D002465:Cell Movement; D049109:Cell Proliferation; D018450:Disease Progression; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D017930:Genes, Reporter; D006801:Humans; D051379:Mice; D008819:Mice, Nude; D035683:MicroRNAs / Q000378:metabolism*; D009368:Neoplasm Transplantation; D012516:Osteosarcoma / Q000235:genetics* / Q000378:metabolism; D051789:Proto-Oncogene Protein c-fli-1 / Q000378:metabolism*
D020413:3' Untranslated Regions; C078433:FLI1 protein, human; C541010:MIRN145 microRNA, human; D035683:MicroRNAs; D051789:Proto-Oncogene Protein c-fli-1
FLI-1; miR-145; osteosarcoma